Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2004 filings

All 36 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2004, sourced directly from the official regulator.

36 Filings
2004 Period
2004 filings (36)
Filing Released Lang
ANP & Isis initiate Phase 2A Trial of Drug 3 pages ?Kb
Regulatory Filings
2004-12-20 English
Animal Study Results Point to ATL1102's Potential 2 pages ?Kb
Regulatory Filings
2004-12-19 English
Appendix 3B - Exercise of options 8 pages ?Kb
Regulatory Filings
2004-12-14 English
Market Developments - New Treatment for MS 1 page ?
Regulatory Filings
2004-11-25 English
Presentation - Institutional Life Science Forum in London 13 pages ?Kb
Regulatory Filings
2004-11-22 English
ATL1101 for Psoriasis 2 pages ?Kb
Regulatory Filings
2004-11-16 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report Q1 2005
2004-10-26 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Capital/Financing Update
2004-10-26 English
To present at Rodman & Renshaw Healthcare Conf in US 1
Regulatory Filings
2004-10-20 English
Chairman's Address & AGM 2004 Presentation 21 pages ?Kb
AGM Information
2004-10-19 English
Results of AGM 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2004-10-19 English
Establish Level 1 ADR Program 1 page ?Kb
Capital/Financing Update
2004-10-05 English
Psoriasis Proof of Concept Study - Update 2 pages ?Kb
Regulatory Filings
2004-09-26 English
Notice of Annual General Meeting & Annual Report 50 pages ?Kb
Proxy Solicitation & Information Statement FY 2004
2004-09-20 English
Preliminary Final Report 39 pages ?Kb
Earnings Release FY 2004
2004-08-25 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Share Issue/Capital Change
2004-08-25 English
Commitments Test Entity - Fourth Quarter Report 6 pages ?Kb
Interim / Quarterly Report FY 2004
2004-07-29 English
Investor Update - Further Market Developments 2 pages ?Kb
Capital/Financing Update
2004-07-27 English
Est new research laboratory at Murdoch Childrens Res Inst 2 pages ?Kb
Regulatory Filings
2004-07-19 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Regulatory Filings
2004-07-08 English
Investor Update - Market Developments re Treatment for MS 2 pages ?Kb
Investor Presentation
2004-06-30 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2004-06-22 English
Positive Results from A Phase 1 Trial of ATL-1102 for MS 4 pages ?Kb
Regulatory Filings
2004-06-07 English
Presentation BIO2004 Annual International Convention 17 pages ?Kb
Investor Presentation
2004-06-06 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Share Issue/Capital Change
2004-06-01 English
Ceasing to be a substantial holder 3 pages ?Kb
Major Shareholding Notification
2004-05-13 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Regulatory Filings
2004-04-28 English
ATL1103 Animal Study Result to be Presented at Int Symposium 10 pages ?Kb
Regulatory Filings
2004-04-19 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Regulatory Filings
2004-04-07 English
Updated Corporate Presentation 17 pages ?Kb
Investor Presentation
2004-03-15 English
Investor Update March 2004 8 pages ?Kb
Investor Presentation
2004-03-11 English
Potential New Treatment for Growth & Sight Disorders 3 pages ?Kb
Regulatory Filings
2004-02-23 English
Half Yearly Report & Half Year Accounts 18 pages ?Kb
Interim / Quarterly Report H1 2004
2004-02-11 English
Preliminary Phase 1 Results-Neurosciences Conf. Presentation 2 pages ?Kb
Investor Presentation
2004-01-29 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report Q2 2003
2004-01-29 English
CEO Mark Diamond Featured Guest on Biotech Today Radio Prog 1
Regulatory Filings
2004-01-13 English